# clm_2DD252AFDAA3

subject: Novartis (/record/novartis.md)  
predicate: operating_income  
value: 14,544,000,000 United States dollar  
valid_from: 2024-12-31  
valid_to: 2025-12-31  
published: 2025-01-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_13AEEBEB19A6  
last_updated: 2026-11-08  
cite: AsOf. "Novartis operating income: 14,544,000,000 United States dollar", as of 2024-12-31 (until 2025-12-31). Claim clm_2DD252AFDAA3, https://asof.is/claim/clm_2DD252AFDAA3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2024, filed 2025-01-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm (primary, SEC EDGAR 20-F FY2024, published 2025-01-31)

## Supersedes

- [Novartis](/record/novartis.md) | operating_income | 9,769,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_2DD252AFDAA3](/claim/clm_2DD252AFDAA3.md) | [clm_C54C261844E4](/claim/clm_C54C261844E4.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.